Vector-borne diseases (VBDs) represent a significant public health challenge in India, necessitating a comprehensive understanding of their epidemiology, control measures, and impact on the healthcare system.
In India, VBDs such as malaria, dengue, chikungunya, and Japanese encephalitis are widespread. The National Vector Borne Disease Control Programme (NVBDCP) reports millions of cases annually. Factors such as climate change, urbanization, and population movement contribute to the high prevalence and geographic spread of these diseases.
VBDs place a significant burden on India's healthcare system. They cause substantial morbidity and mortality, leading to high healthcare costs and productivity loss. The strain on healthcare resources is especially pronounced during outbreaks, with hospitals often grappling with bed shortages and overworked staff.
Efforts to control VBDs in India include vector control, disease surveillance, early diagnosis and treatment, and public health education. However, challenges such as insecticide resistance, lack of public awareness, and gaps in surveillance and reporting systems persist. The development and implementation of effective vaccines also remain a key area of focus.
Healthcare professionals play a critical role in managing VBDs. They are at the forefront of early diagnosis and treatment, patient education, and advocacy for public health measures. Their understanding of the epidemiology and control of VBDs is essential for effective disease management and control.
The burden of VBDs in India is substantial, with significant implications for the healthcare system. Comprehensive understanding and strategic interventions are crucial to mitigate this public health challenge. Healthcare professionals, with their pivotal role, are key to achieving this goal.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation